(1) How much stock of the registered tuberculosis vaccine, Bacillus Calmette-Guerin (BCG), is available in the country as at the latest specified date for which information is available; (2) (a) how much of the unregistered version of BCG was recently imported, (b) when did each specified batch arrive in the country and (c) where was each specified batch imported from; (3) what is his department’s plan to ensure a sufficient supply of BCG in the foreseeable future?